BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 33189027)

  • 1. Retrospective Observational Study on Riboflavin Prophylaxis in Child and Adolescent Migraine.
    Das R; Qubty W
    Pediatr Neurol; 2021 Jan; 114():5-8. PubMed ID: 33189027
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An observational study of fixed-dose Tanacetum parthenium nutraceutical preparation for prophylaxis of pediatric headache.
    Moscano F; Guiducci M; Maltoni L; Striano P; Ledda MG; Zoroddu F; Raucci U; Villa MP; Parisi P
    Ital J Pediatr; 2019 Mar; 45(1):36. PubMed ID: 30871574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of low-dose riboflavin as a prophylactic agent in pediatric migraine.
    Yamanaka G; Suzuki S; Takeshita M; Go S; Morishita N; Takamatsu T; Daida A; Morichi S; Ishida Y; Oana S; Nara S; Shimura M; Nishimata S; Kawashima H
    Brain Dev; 2020 Aug; 42(7):523-528. PubMed ID: 32336482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Supplementation with Riboflavin (Vitamin B2) for Migraine Prophylaxis in Adults and Children: A Review.
    Namazi N; Heshmati J; Tarighat-Esfanjani A
    Int J Vitam Nutr Res; 2015; 85(1-2):79-87. PubMed ID: 26780280
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High-dose riboflavin treatment is efficacious in migraine prophylaxis: an open study in a tertiary care centre.
    Boehnke C; Reuter U; Flach U; Schuh-Hofer S; Einhäupl KM; Arnold G
    Eur J Neurol; 2004 Jul; 11(7):475-7. PubMed ID: 15257686
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riboflavin prophylaxis in pediatric and adolescent migraine.
    Condò M; Posar A; Arbizzani A; Parmeggiani A
    J Headache Pain; 2009 Oct; 10(5):361-5. PubMed ID: 19649688
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prophylaxis of migraine headaches with riboflavin: A systematic review.
    Thompson DF; Saluja HS
    J Clin Pharm Ther; 2017 Aug; 42(4):394-403. PubMed ID: 28485121
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-dose riboflavin for migraine prophylaxis in children: a double-blind, randomized, placebo-controlled trial.
    MacLennan SC; Wade FM; Forrest KM; Ratanayake PD; Fagan E; Antony J
    J Child Neurol; 2008 Nov; 23(11):1300-4. PubMed ID: 18984840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Improvement of migraine symptoms with a proprietary supplement containing riboflavin, magnesium and Q10: a randomized, placebo-controlled, double-blind, multicenter trial.
    Gaul C; Diener HC; Danesch U;
    J Headache Pain; 2015; 16():516. PubMed ID: 25916335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medium-dose riboflavin as a prophylactic agent in children with migraine: a preliminary placebo-controlled, randomised, double-blind, cross-over trial.
    Bruijn J; Duivenvoorden H; Passchier J; Locher H; Dijkstra N; Arts WF
    Cephalalgia; 2010 Dec; 30(12):1426-34. PubMed ID: 20974610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomized trial of propranolol versus sodium valproate for the prophylaxis of migraine in pediatric patients.
    Bidabadi E; Mashouf M
    Paediatr Drugs; 2010 Aug; 12(4):269-75. PubMed ID: 20593910
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effectiveness of riboflavin in pediatric migraine prevention.
    Sherwood M; Goldman RD
    Can Fam Physician; 2014 Mar; 60(3):244-6. PubMed ID: 24627379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nutraceuticals safety and efficacy in migraine without aura in a population of children affected by neurofibromatosis type I.
    Carotenuto M; Esposito M
    Neurol Sci; 2013 Nov; 34(11):1905-9. PubMed ID: 23532548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prophylactic treatment of pediatric migraine.
    Lewis DW; Diamond S; Scott D; Jones V
    Headache; 2004 Mar; 44(3):230-7. PubMed ID: 15012660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nutraceuticals in the prophylaxis of pediatric migraine: Evidence-based review and recommendations.
    Orr SL; Venkateswaran S
    Cephalalgia; 2014 Jul; 34(8):568-83. PubMed ID: 24443395
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Profile and Prognosis of Youth With Status Migrainosus: Results From an Observational Study.
    Orr SL; Turner A; Kabbouche MA; Horn PS; O'Brien HL; Kacperski J; LeCates S; White S; Weberding J; Miller MN; Powers SW; Hershey AD
    Headache; 2020 May; 60(5):878-888. PubMed ID: 32031255
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Real-World Patient Experience With Erenumab for the Preventive Treatment of Migraine.
    Robblee J; Devick KL; Mendez N; Potter J; Slonaker J; Starling AJ
    Headache; 2020 Oct; 60(9):2014-2025. PubMed ID: 32920850
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Usefulness of nutraceuticals in migraine prophylaxis.
    D'Onofrio F; Raimo S; Spitaleri D; Casucci G; Bussone G
    Neurol Sci; 2017 May; 38(Suppl 1):117-120. PubMed ID: 28527067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Failure of preventive treatments in migraine: an observational retrospective study in a tertiary headache center.
    Delussi M; Vecchio E; Libro G; Quitadamo S; de Tommaso M
    BMC Neurol; 2020 Jun; 20(1):256. PubMed ID: 32593298
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effectiveness of high-dose riboflavin in migraine prophylaxis. A randomized controlled trial.
    Schoenen J; Jacquy J; Lenaerts M
    Neurology; 1998 Feb; 50(2):466-70. PubMed ID: 9484373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.